The role of AGR2 and AGR3 in cancer: Similar but not identical

European Journal of Cell Biology

Volumn 94, Issue 3-4, 2015, Pages 139-147

  Obacz, Joanna ^a,b   Takacova, Martina ^a,b   Brychtova, Veronika ^a   Dobes, Petr ^a   Pastorekova, Silvia ^a,b   Vojtesek, Borivoj ^a   Hrstka, Roman ^a  

^a MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

^b INSTITUTE OF VIROLOGY   (Slovakia)

Author keywords

AGR2; AGR3; Cancer; PDI family

Indexed keywords

AGR2 PROTEIN; AGR3 PROTEIN; CISPLATIN; PROTEIN DISULFIDE ISOMERASE; UNCLASSIFIED DRUG; AGR2 PROTEIN, HUMAN; AGR3 PROTEIN, HUMAN; CARRIER PROTEIN; PROTEIN; TUMOR PROTEIN;

BREAST CANCER; CANCER TISSUE; CARCINOMA; CELL METABOLISM; CELL MIGRATION; CELL PROLIFERATION; COMPUTER MODEL; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIVER CANCER; MCF 7 CELL LINE; METASTASIS; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEQUENCE HOMOLOGY; SHORT SURVEY; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR DIFFERENTIATION; TUMOR GROWTH; TUMOR INVASION; CELL DIFFERENTIATION; CELL MOTION; COMPUTER SIMULATION; METABOLISM; PATHOLOGY;

CARRIER PROTEINS; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; COMPUTER SIMULATION; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NEOPLASMS; PROTEINS;

EID: 84973231817     PISSN: 01719335     EISSN: 16181298     Source Type: Journal    
DOI: 10.1016/j.ejcb.2015.01.002     Document Type: Short Survey

References (100)

1. Aberger F., Weidinger G., Grunz H., Richter K. Anterior specification of embryonic ectoderm: the role of the Xenopus cement gland-specific gene XAG-2. Mech. Dev. 1998, 72:115-130.
2. Adam P.J., Boyd R., Tyson K.L., Fletcher G.C., Stamps A., Hudson L., et al. Comprehensive proteomic analysis of breast cancer cell membranes reveals unique proteins with potential roles in clinical cancer. J. Biol. Chem. 2003, 278:6482-6489.
3. Appenzeller-Herzog C., Ellgaard L. The human PDI family: versatility packed into a single fold. Biochim. Biophys. Acta 2008, 1783:535-548.
4. Armes J.E., Davies C.M., Wallace S., Taheri T., Perrin L.C., Autelitano D.J. AGR2 expression in ovarian tumours: a potential biomarker for endometrioid and mucinous differentiation. Pathology 2013, 45:49-54.
5. Bai Z., Ye Y., Liang B., Xu F., Zhang H., Zhang Y., et al. Proteomics-based identification of a group of apoptosis-related proteins and biomarkers in gastric cancer. Int. J. Oncol. 2011, 38:375-383.
6. Benham A.M. The protein disulfide isomerase family: key players in health and disease. Antioxid. Redox Signal. 2012, 16:781-789.
7. Bergstrom J.H., Berg K.A., Rodriguez-Pineiro A.M., Stecher B., Johansson M.E., Hansson G.C. AGR2, an endoplasmic reticulum protein, is secreted into the gastrointestinal mucus. PLoS ONE 2014, 9:e104186.
8. Brabletz S., Brabletz T. The ZEB/miR-200 feedback loop-a motor of cellular plasticity in development and cancer?. EMBO Rep. 2010, 11:670-677.
9. Browne G., Sayan A.E., Tulchinsky E. ZEB proteins link cell motility with cell cycle control and cell survival in cancer. Cell Cycle 2010, 9:886-891.
10. Brychtova V., Vojtesek B., Hrstka R. Anterior gradient 2: a novel player in tumor cell biology. Cancer Lett. 2011, 304:1-7.
11. Brychtova V., Zampachova V., Hrstka R., Fabian P., Novak J., Hermanova M., et al. Differential expression of anterior gradient protein 3 in intrahepatic cholangiocarcinoma and hepatocellular carcinoma. Exp. Mol. Pathol. 2014, 96:375-381.
12. Bu H., Bormann S., Schafer G., Horninger W., Massoner P., Neeb A., et al. The anterior gradient 2 (AGR2) gene is overexpressed in prostate cancer and may be useful as a urine sediment marker for prostate cancer detection. Prostate 2011, 71:575-587.
13. Bu H., Schweiger M.R., Manke T., Wunderlich A., Timmermann B., Kerick M., et al. Anterior gradient 2 and 3-two prototype androgen-responsive genes transcriptionally upregulated by androgens and by oestrogens in prostate cancer cells. FEBS J. 2013, 280:1249-1266.
14. Cartharius K., Frech K., Grote K., Klocke B., Haltmeier M., Klingenhoff A., et al. MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 2005, 21:2933-2942.
15. Chen Y.C., Lu Y.F., Li I.C., Hwang S.P. Zebrafish Agr2 is required for terminal differentiation of intestinal goblet cells. PLoS ONE 2012, 7:e34408.
16. Chevet E., Fessart D., Delom F., Mulot A., Vojtesek B., Hrstka R., et al. Emerging roles for the pro-oncogenic anterior gradient-2 in cancer development. Oncogene 2013, 32:2499-2509.
17. Chung Moh M., Hoon Lee L., Shen S. Cloning and characterization of hepaCAM, a novel Ig-like cell adhesion molecule suppressed in human hepatocellular carcinoma. J. Hepatol. 2005, 42:833-841.
18. Darb-Esfahani S., Fritzsche F., Kristiansen G., Weichert W., Sehouli J., Braicu I., et al. Anterior gradient protein 2 (AGR2) is an independent prognostic factor in ovarian high-grade serous carcinoma. Virch. Arch. 2012, 461:109-116.
19. de Souza W.F., Fortunato-Miranda N., Robbs B.K., de Araujo W.M., de-Freitas-Junior J.C., Bastos L.G., et al. Claudin-3 overexpression increases the malignant potential of colorectal cancer cells: roles of ERK1/2 and PI3K-Akt as modulators of EGFR signaling. PLoS ONE 2013, 8:e74994.
20. Dumartin L., Whiteman H.J., Weeks M.E., Hariharan D., Dmitrovic B., Iacobuzio-Donahue C.A., et al. AGR2 is a novel surface antigen that promotes the dissemination of pancreatic cancer cells through regulation of cathepsins B and D. Cancer Res. 2011, 71:7091-7102.
21. Edgell T.A., Barraclough D.L., Rajic A., Dhulia J., Lewis K.J., Armes J.E., et al. Increased plasma concentrations of anterior gradient 2 protein are positively associated with ovarian cancer. Clin. Sci. (Lond.) 2010, 118:717-725.
22. Fletcher G.C., Patel S., Tyson K., Adam P.J., Schenker M., Loader J.A., et al. hAG-2 and hAG-3, human homologues of genes involved in differentiation, are associated with oestrogen receptor-positive breast tumours and interact with metastasis gene C4.4a and dystroglycan. Br. J. Cancer 2003, 88:579-585.
23. Galligan J.J., Petersen D.R. The human protein disulfide isomerase gene family. Hum. Genom. 2012, 6:6.
24. Gray T.A., MacLaine N.J., Michie C.O., Bouchalova P., Murray E., Howie J., et al. Anterior gradient-3: a novel biomarker for ovarian cancer that mediates cisplatin resistance in xenograft models. J. Immunol. Methods 2012, 378:20-32.
25. Hata S., Abe M., Suzuki H., Kitamura F., Toyama-Sorimachi N., Abe K., et al. Calpain 8/nCL-2 and calpain 9/nCL-4 constitute an active protease complex, G-calpain, involved in gastric mucosal defense. PLoS Genet. 2010, 6:e1001040.
26. Hatahet F., Ruddock L.W. Protein disulfide isomerase: a critical evaluation of its function in disulfide bond formation. Antioxid. Redox Signal. 2009, 11:2807-2850.
27. He T.C., Sparks A.B., Rago C., Hermeking H., Zawel L., da Costa L.T., et al. Identification of c-MYC as a target of the APC pathway. Science 1998, 281:1509-1512.
28. Higa A., Mulot A., Delom F., Bouchecareilh M., Nguyen D.T., Boismenu D., et al. Role of pro-oncogenic protein disulfide isomerase (PDI) family member anterior gradient 2 (AGR2) in the control of endoplasmic reticulum homeostasis. J. Biol. Chem. 2011, 286:44855-44868.
29. Hrstka R., Nenutil R., Fourtouna A., Maslon M.M., Naughton C., Langdon S., et al. The pro-metastatic protein anterior gradient-2 predicts poor prognosis in tamoxifen-treated breast cancers. Oncogene 2010, 29:4838-4847.
30. Hruz T., Laule O., Szabo G., Wessendorp F., Bleuler S., Oertle L., et al. Genevestigator v3: a reference expression database for the meta-analysis of transcriptomes. Adv. Bioinformatics 2008, 2008:420747.
31. Huynh H. Induction of apoptosis in rat ventral prostate by finasteride is associated with alteration in MAP kinase pathways and Bcl-2 related family of proteins. Int. J. Oncol. 2002, 20:1297-1303.
32. Imamura T., Hikita A., Inoue Y. The roles of TGF-beta signaling in carcinogenesis and breast cancer metastasis. Breast Cancer 2012, 19:118-124.
33. Ivanova A.S., Tereshina M.B., Ermakova G.V., Belousov V.V., Zaraisky A.G. Agr genes, missing in amniotes, are involved in the body appendages regeneration in frog tadpoles. Sci. Rep. 2013, 3:1279.
34. Izquierdo L., Mengual L., Gazquez C., Ingelmo-Torres M., Alcaraz A. Molecular characterization of upper urinary tract tumours. BJU Int. 2010, 106:868-872.
35. Jacquot J.P., Gelhaye E., Rouhier N., Corbier C., Didierjean C., Aubry A. Thioredoxins and related proteins in photosynthetic organisms: molecular basis for thiol dependent regulation. Biochem. Pharmacol. 2002, 64:1065-1069.
36. Janknecht R., Ernst W.H., Pingoud V., Nordheim A. Activation of ternary complex factor Elk-1 by MAP kinases. EMBO J. 1993, 12:5097-5104.
37. Jarriault S., Brou C., Logeat F., Schroeter E.H., Kopan R., Israel A. Signalling downstream of activated mammalian Notch. Nature 1995, 377:355-358.
38. King E.R., Tung C.S., Tsang Y.T., Zu Z., Lok G.T., Deavers M.T., et al. The anterior gradient homolog 3 (AGR3) gene is associated with differentiation and survival in ovarian cancer. Am. J. Surg. Pathol. 2011, 35:904-912.
39. Kitisin K., Saha T., Blake T., Golestaneh N., Deng M., Kim C., et al. Tgf-Beta signaling in development. Sci. STKE 2007, 2007:cm1.
40. Koon H.B., Ippolito G.C., Banham A.H., Tucker P.W. FOXP1: a potential therapeutic target in cancer. Expert Opin. Ther. Targets 2007, 11:955-965.
41. Koul H.K., Pal M., Koul S. Role of p38 MAP kinase signal transduction in solid tumors. Genes Cancer 2013, 4:342-359.
42. Kozlov G., Maattanen P., Thomas D.Y., Gehring K. A structural overview of the PDI family of proteins. FEBS J. 2010, 277:3924-3936.
43. Kumar A., Godwin J.W., Gates P.B., Garza-Garcia A.A., Brockes J.P. Molecular basis for the nerve dependence of limb regeneration in an adult vertebrate. Science 2007, 318:772-777.
44. Lai E.C. Notch signaling: control of cell communication and cell fate. Development 2004, 131:965-973.
45. Lee H.J., Sorimachi H., Jeong S.Y., Ishiura S., Suzuki K. Molecular cloning and characterization of a novel tissue-specific calpain predominantly expressed in the digestive tract. Biol. Chem. 1998, 379:175-183.
46. Lee S., Bang S., Song K., Lee I. Differential expression in normal-adenoma-carcinoma sequence suggests complex molecular carcinogenesis in colon. Oncol. Rep. 2006, 16:747-754.
47. Lepreux S., Bioulac-Sage P., Chevet E. Differential expression of the anterior gradient protein-2 is a conserved feature during morphogenesis and carcinogenesis of the biliary tree. Liver Int. 2011, 31:322-328.
48. Lin X., Shang X., Manorek G., Howell S.B. Regulation of the epithelial-mesenchymal transition by claudin-3 and claudin-4. PLoS ONE 2013, 8:e67496.
49. Liu D., Rudland P.S., Sibson D.R., Platt-Higgins A., Barraclough R. Human homologue of cement gland protein, a novel metastasis inducer associated with breast carcinomas. Cancer Res. 2005, 65:3796-3805.
50. Maslon M.M., Hrstka R., Vojtesek B., Hupp T.R. A divergent substrate-binding loop within the pro-oncogenic protein anterior gradient-2 forms a docking site for Reptin. J. Mol. Biol. 2010, 404:418-438.
51. Moh M.C., Zhang C., Luo C., Lee L.H., Shen S. Structural and functional analyses of a novel Ig-like cell adhesion molecule, hepaCAM, in the human breast carcinoma MCF7 cells. J. Biol. Chem. 2005, 280:27366-27374.
52. Moh M.C., Zhang T., Lee L.H., Shen S. Expression of hepaCAM is downregulated in cancers and induces senescence-like growth arrest via a p53/p21-dependent pathway in human breast cancer cells. Carcinogenesis 2008, 29:2298-2305.
53. Ni M., Lee A.S. ER chaperones in mammalian development and human diseases. FEBS Lett. 2007, 581:3641-3651.
54. Norris A.M., Gore A., Balboni A., Young A., Longnecker D.S., Korc M. AGR2 is a SMAD4-suppressible gene that modulates MUC1 levels and promotes the initiation and progression of pancreatic intraepithelial neoplasia. Oncogene 2013, 32:3867-3876.
55. Park K., Chung Y.J., So H., Kim K., Park J., Oh M., et al. AGR2, a mucinous ovarian cancer marker, promotes cell proliferation and migration. Exp. Mol. Med. 2011, 43:91-100.
56. Park S.W., Zhen G., Verhaeghe C., Nakagami Y., Nguyenvu L.T., Barczak A.J., et al. The protein disulfide isomerase AGR2 is essential for production of intestinal mucus. Proc. Natl Acad. Sci. U.S.A. 2009, 106:6950-6955.
57. Patel P., Clarke C., Barraclough D.L., Jowitt T.A., Rudland P.S., Barraclough R., et al. Metastasis-promoting anterior gradient 2 protein has a dimeric thioredoxin fold structure and a role in cell adhesion. J. Mol. Biol. 2013, 425:929-943.
58. Persson S., Rosenquist M., Knoblach B., Khosravi-Far R., Sommarin M., Michalak M. Diversity of the protein disulfide isomerase family: identification of breast tumor induced Hag2 and Hag3 as novel members of the protein family. Mol. Phylogenet. Evol. 2005, 36:734-740.
59. Petek E., Windpassinger C., Egger H., Kroisel P.M., Wagner K. Localization of the human anterior gradient-2 gene (AGR2) to chromosome band 7p21.3 by radiation hybrid mapping and fluorescence in situ hybridisation. Cytogenet. Cell Genet. 2000, 89:141-142.
60. Pizzi M., Fassan M., Balistreri M., Galligioni A., Rea F., Rugge M. Anterior gradient 2 overexpression in lung adenocarcinoma. Appl. Immunohistochem. Mol. Morphol. 2012, 20:31-36.
61. Quandt K., Frech K., Karas H., Wingender E., Werner T. MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 1995, 23:4878-4884.
62. Ramachandran V., Arumugam T., Wang H., Logsdon C.D. Anterior gradient 2 is expressed and secreted during the development of pancreatic cancer and promotes cancer cell survival. Cancer Res. 2008, 68:7811-7818.
63. Rawlings J.S., Rosler K.M., Harrison D.A. The JAK/STAT signaling pathway. J. Cell Sci. 2004, 117:1281-1283.
64. Reya T., Clevers H. Wnt signalling in stem cells and cancer. Nature 2005, 434:843-850.
65. Richardson M.M., Jennings L.K., Zhang X.A. Tetraspanins and tumor progression. Clin. Exp. Metastasis 2011, 28:261-270.
66. Ron D., Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat. Rev. Mol. Cell Biol. 2007, 8:519-529.
67. Ryu J., Park S.G., Lee P.Y., Cho S., Lee do H., Kim G.H., et al. Dimerization of pro-oncogenic protein anterior gradient 2 is required for the interaction with BiP/GRP78. Biochem. Biophys. Res. Commun. 2013, 430:610-615.
68. Salmans M.L., Zhao F., Andersen B. The estrogen-regulated anterior gradient 2 (AGR2) protein in breast cancer: a potential drug target and biomarker. Breast Cancer Res. 2013, 15:204.
69. Schier A.F., Shen M.M. Nodal signalling in vertebrate development. Nature 2000, 403:385-389.
70. Schroeder B.W., Verhaeghe C., Park S.W., Nguyenvu L.T., Huang X., Zhen G., et al. AGR2 is induced in asthma and promotes allergen-induced mucin overproduction. Am. J. Respir. Cell Mol. Biol. 2012, 47:178-185.
71. Shang X., Lin X., Alvarez E., Manorek G., Howell S.B. Tight junction proteins claudin-3 and claudin-4 control tumor growth and metastases. Neoplasia 2012, 14:974-985.
72. Shang X., Lin X., Manorek G., Howell S.B. Claudin-3 and claudin-4 regulate sensitivity to cisplatin by controlling expression of the copper and cisplatin influx transporter CTR1. Mol. Pharmacol. 2013, 83:85-94.
73. Shigekawa T., Ijichi N., Ikeda K., Horie-Inoue K., Shimizu C., Saji S., et al. FOXP1, an estrogen-inducible transcription factor, modulates cell proliferation in breast cancer cells and 5-year recurrence-free survival of patients with tamoxifen-treated breast cancer. Horm. Cancer 2011, 2:286-297.
74. Shtutman M., Zhurinsky J., Simcha I., Albanese C., D'Amico M., Pestell R., et al. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc. Natl Acad. Sci. U.S.A. 1999, 96:5522-5527.
75. Sive H.L., Hattori K., Weintraub H. Progressive determination during formation of the anteroposterior axis in Xenopus laevis. Cell 1989, 58:171-180.
76. Sorimachi H., Ishiura S., Suzuki K. A novel tissue-specific calpain species expressed predominantly in the stomach comprises two alternative splicing products with and without Ca(2+)-binding domain. J. Biol. Chem. 1993, 268:19476-19482.
77. Storr S.J., Carragher N.O., Frame M.C., Parr T., Martin S.G. The calpain system and cancer. Nat. Rev. Cancer 2011, 11:364-374.
78. Sui X., Kong N., Ye L., Han W., Zhou J., Zhang Q., et al. p38 and JNK MAPK pathways control the balance of apoptosis and autophagy in response to chemotherapeutic agents. Cancer Lett. 2014, 344:174-179.
79. Sweeny L., Liu Z., Bush B.D., Hartman Y., Zhou T., Rosenthal E.L. CD147 and AGR2 expression promote cellular proliferation and metastasis of head and neck squamous cell carcinoma. Exp. Cell Res. 2012, 318:1788-1798.
80. Tabas I., Ron D. Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress. Nat. Cell Biol. 2011, 13:184-190.
81. Tereshina M.B., Ermakova G.V., Ivanova A.S., Zaraisky A.G. Ras-dva1 small GTPase regulates telencephalon development in Xenopus laevis embryos by controlling Fgf8 and Agr signaling at the anterior border of the neural plate. Biol. Open 2014, 3:192-203.
82. Thiery J.P., Acloque H., Huang R.Y., Nieto M.A. Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139:871-890.
83. Thompson D.A., Weigel R.J. hAG-2, the human homologue of the Xenopus laevis cement gland gene XAG-2, is coexpressed with estrogen receptor in breast cancer cell lines. Biochem. Biophys. Res. Commun. 1998, 251:111-116.
84. Turano C., Coppari S., Altieri F., Ferraro A. Proteins of the PDI family: unpredicted non-ER locations and functions. J. Cell. Physiol. 2002, 193:154-163.
85. Vaarala M.H., Hirvikoski P., Kauppila S., Paavonen T.K. Identification of androgen-regulated genes in human prostate. Mol. Med. Rep. 2012, 6:466-472.
86. Valladares-Ayerbes M., Diaz-Prado S., Reboredo M., Medina V., Iglesias-Diaz P., Lorenzo-Patino M.J., et al. Bioinformatics approach to mRNA markers discovery for detection of circulating tumor cells in patients with gastrointestinal cancer. Cancer Detect. Prev. 2008, 32:236-250.
87. Vanderlaag K.E., Hudak S., Bald L., Fayadat-Dilman L., Sathe M., Grein J., et al. Anterior gradient-2 plays a critical role in breast cancer cell growth and survival by modulating cyclin D1, estrogen receptor-alpha and survivin. Breast Cancer Res. 2010, 12:R32.
88. Verma S., Salmans M.L., Geyfman M., Wang H., Yu Z., Lu Z., et al. The estrogen-responsive Agr2 gene regulates mammary epithelial proliferation and facilitates lobuloalveolar development. Dev. Biol. 2012, 369:249-260.
89. Vivekanandan P., Micchelli S.T., Torbenson M. Anterior gradient-2 is overexpressed by fibrolamellar carcinomas. Hum. Pathol. 2009, 40:293-299.
90. Wang Q., Luo C., Wu X., Du H., Song X., Fan Y. hepaCAM and p-mTOR closely correlate in bladder transitional cell carcinoma and hepaCAM expression inhibits proliferation via an AMPK/mTOR dependent pathway in human bladder cancer cells. J. Urol. 2013, 190:1912-1918.
91. Welboren W.J., van Driel M.A., Janssen-Megens E.M., van Heeringen S.J., Sweep F.C., Span P.N., et al. ChIP-Seq of ERalpha and RNA polymerase II defines genes differentially responding to ligands. EMBO J. 2009, 28:1418-1428.
92. Wilson C.L., Sims A.H., Howell A., Miller C.J., Clarke R.B. Effects of oestrogen on gene expression in epithelium and stroma of normal human breast tissue. Endocr. Relat. Cancer 2006, 13:617-628.
93. Wotton D., Lo R.S., Lee S., Massague J. A Smad transcriptional corepressor. Cell 1999, 97:29-39.
94. Wright T.M., Wardell S.E., Jasper J.S., Stice J.P., Safi R., Nelson E.R., et al. Delineation of a FOXA1/ERalpha/AGR2 regulatory loop that is dysregulated in endocrine therapy-resistant breast cancer. Mol. Cancer Res. 2014.
95. Xia J.H., Jiang J., Shi Y.H., Gui J.F. Predominant expression and cellular distribution of fish Agr2 in renal collecting system. Comp. Biochem. Physiol. B: Biochem. Mol. Biol. 2009, 152:397-404.
96. Yoshikawa Y., Mukai H., Hino F., Asada K., Kato I. Isolation of two novel genes, down-regulated in gastric cancer. Jpn. J. Cancer Res. 2000, 91:459-463.
97. Zhang J.S., Gong A., Cheville J.C., Smith D.I., Young C.Y. AGR2, an androgen-inducible secretory protein overexpressed in prostate cancer. Genes Chromosomes Cancer 2005, 43:249-259.
98. Zhang Q.L., Luo C.L., Wu X.H., Wang C.Y., Xu X., Zhang Y.Y., et al. HepaCAM induces G1 phase arrest and promotes c-Myc degradation in human renal cell carcinoma. J. Cell. Biochem. 2011, 112:2910-2919.
99. Zhang Y., Ali T.Z., Zhou H., D'Souza D.R., Lu Y., Jaffe J., et al. ErbB3 binding protein 1 represses metastasis-promoting gene anterior gradient protein 2 in prostate cancer. Cancer Res. 2010, 70:240-248.
100. Zheng W., Rosenstiel P., Huse K., Sina C., Valentonyte R., Mah N., et al. Evaluation of AGR2 and AGR3 as candidate genes for inflammatory bowel disease. Genes Immun. 2006, 7:11-18.